Many of the most-read articles from the print issues of Managed Healthcare Executive® focused on the cost of therapies.
Governments are the only buyers so far, and the amounts they are paying varies.
Screening and some care have been canceled or deferred. Will more illness and deaths result?
Low prices and some gaming of regulations can drive out competitors and create monopolies that allow generic makers to jack up their prices. Experience has shown that it often takes multiple generics to achieve the promised-for downward pressure on prices.
PBMs say exclusions are important for negotiating lower prices on behalf of health plans and members. Some payer and provider groups say they interfere with patient access to medicines.
Having specialty pharmacies fill prescriptions may lower costs, but critics of the practice see safety issues and other drawbacks.
New ATS Guidelines Highlight Benefits of Pulmonary Rehabilitation
February 7th 2025Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved quality of life and functional capacity as measured in the 6-minute walk distance test.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Trump Administration Throws U.S. AIDS Support into Turmoil
February 6th 2025PEPFAR, the main U.S.-funded global AIDS program was given a waiver from the foreign aid freeze, but there is still uncertainty and interruptions, partly because many PEPFAR programs are implemented through USAID, which has been largely shutdown by the news administration.
Read More